| Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Journal of Natural Products | 2012 | 3.4K |
| Identification of acquired antimicrobial resistance genes | Journal of Antimicrobial Chemotherapy | 2012 | 2.9K |
| Doxil®--the first FDA-approved nano-drug: lessons learned | Journal of Controlled Release | 2012 | 2.6K |
| PLGA-based nanoparticles: an overview of biomedical applications | Journal of Controlled Release | 2012 | 2.2K |
| Hydrogels for biomedical applications | Advanced Drug Delivery Reviews | 2012 | 2K |
| Designing nanostructured Si anodes for high energy lithium ion batteries | Nano Today | 2012 | 1.5K |
| The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles | International Journal of Nanomedicine | 2012 | 1.5K |
| Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects | International Nano Letters | 2012 | 1.3K |
| The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review | Neurotherapeutics | 2012 | 1.2K |
| Pharmacogenomics knowledge for personalized medicine | Clinical Pharmacology and Therapeutics | 2012 | 1.2K |
| Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases | Nature Reviews Drug Discovery | 2012 | 1.2K |
| Diagnosing the decline in pharmaceutical R&D efficiency | Nature Reviews Drug Discovery | 2012 | 1.2K |
| Classification, functions, and clinical relevance of extracellular vesicles | Pharmacological Reviews | 2012 | 1.1K |
| Emerging organic contaminants in groundwater: A review of sources, fate and occurrence | Environmental Pollution | 2012 | 1.1K |
| Autophagy modulation as a potential therapeutic target for diverse diseases | Nature Reviews Drug Discovery | 2012 | 1.1K |
| Toxicity of lead: A review with recent updates | Interdisciplinary Toxicology | 2012 | 1.1K |
| PAH diagnostic ratios for the identification of pollution emission sources | Environmental Pollution | 2012 | 1K |
| Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking | Journal of Medicinal Chemistry | 2012 | 1K |
| Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy | Trends in Pharmacological Sciences | 2012 | 1K |
| Epigenetic protein families: a new frontier for drug discovery | Nature Reviews Drug Discovery | 2012 | 1K |
| Microneedles for drug and vaccine delivery | Advanced Drug Delivery Reviews | 2012 | 993 |
| Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging | Nanomedicine: Nanotechnology, Biology, and Medicine | 2012 | 983 |
| Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress | Journal of Controlled Release | 2012 | 983 |
| Targeting the TGFβ signalling pathway in disease | Nature Reviews Drug Discovery | 2012 | 980 |
| Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers | Advanced Drug Delivery Reviews | 2012 | 975 |
